Creative Biolabs-Immuno-oncology

Anti-CD5 (clone 2EF7J) SynExpress C-Cy2-cJ-H Modified CD8+ T cells (CAT#: ITS-1224-CR1677)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD5 (clone 2EF7J). We employs the HBV (CMV-Cy2-c-Jun-HindIII) vector components and the SynExpress system of the miRNA Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD5
Clone
2EF7J
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy2
Promoter
CMV
Effector Gene
c-Jun
Insertion Sites
HindIII
Gene Modification
Knock-in
Modification Domain
miRNA
Carrier Type
HBV
Transformation Accuracy
0.99
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.